Knott David M Jr Verona Pharma PLC Transaction History
Knott David M Jr
- $160 Million
- Q1 2025
A detailed history of Knott David M Jr transactions in Verona Pharma PLC stock. As of the latest transaction made, Knott David M Jr holds 88,000 shares of VRNA stock, worth $8.14 Million. This represents 3.5% of its overall portfolio holdings.
Number of Shares
88,000
Previous 159,300
44.76%
Holding current value
$8.14 Million
Previous $7.4 Million
24.47%
% of portfolio
3.5%
Previous 4.27%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$607 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$511 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$363 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$320 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$268 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $5.64B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...